[go: up one dir, main page]

WO2009043987A9 - Antibiotic compositions containing essential oils, prophylaxis and treatment of nosocomial diseases - Google Patents

Antibiotic compositions containing essential oils, prophylaxis and treatment of nosocomial diseases Download PDF

Info

Publication number
WO2009043987A9
WO2009043987A9 PCT/FR2008/001012 FR2008001012W WO2009043987A9 WO 2009043987 A9 WO2009043987 A9 WO 2009043987A9 FR 2008001012 W FR2008001012 W FR 2008001012W WO 2009043987 A9 WO2009043987 A9 WO 2009043987A9
Authority
WO
WIPO (PCT)
Prior art keywords
prophylaxis
treatment
containing essential
compositions containing
essential oils
Prior art date
Application number
PCT/FR2008/001012
Other languages
French (fr)
Other versions
WO2009043987A1 (en
Inventor
Elisabeth Marie-Ange Yvette Rossines
Gérard Panhelleux
Original Assignee
Aroma Technologies
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aroma Technologies filed Critical Aroma Technologies
Priority to EP08834729A priority Critical patent/EP2175870A1/en
Publication of WO2009043987A1 publication Critical patent/WO2009043987A1/en
Publication of WO2009043987A9 publication Critical patent/WO2009043987A9/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A61K31/431—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems containing further heterocyclic rings, e.g. ticarcillin, azlocillin, oxacillin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The invention set forth in the present application relates to a novel antibiotic composition, to novel drug associations and novel formulations containing essential oil(s), as well as to the use thereof for the prophylaxis and/or treatment of infections in general and of nosocomial bacterial infections in particular. The invention also relates to a method for reducing the amount of bacteria present on a surface. The invention also relates to a method for preventing or treating a bacterial infection, in particular a nosocomial infection, in a mammal and particularly a human being, said method comprising (i) the administration of at least one antibiotic and (ii) the administration of at least one essential oil(s) formulation. The compounds (i) and (ii) can be administered simultaneously (in the form of a mixture or alternatively in the form of separate formulations) and/or separately.
PCT/FR2008/001012 2007-07-10 2008-07-10 Antibiotic compositions containing essential oils, prophylaxis and treatment of nosocomial diseases WO2009043987A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP08834729A EP2175870A1 (en) 2007-07-10 2008-07-10 Antibiotic compositions containing essential oils, prophylaxis and treatment of nosocomial diseases

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0704991A FR2918571B1 (en) 2007-07-10 2007-07-10 ANTIBIOTIC COMPOSITIONS BASED ON ESSENTIAL OILS PROPHYLAXIS AND TREATMENT OF NOSOCOMIAL INFECTIONS
FR0704991 2007-07-10

Publications (2)

Publication Number Publication Date
WO2009043987A1 WO2009043987A1 (en) 2009-04-09
WO2009043987A9 true WO2009043987A9 (en) 2009-10-01

Family

ID=39135270

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2008/001012 WO2009043987A1 (en) 2007-07-10 2008-07-10 Antibiotic compositions containing essential oils, prophylaxis and treatment of nosocomial diseases

Country Status (3)

Country Link
EP (1) EP2175870A1 (en)
FR (1) FR2918571B1 (en)
WO (1) WO2009043987A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2946255B1 (en) * 2009-06-05 2013-05-24 Natepharm COMPOSITION COMPRISING TRANS-CINNAMALDEHYDE
IT1401202B1 (en) * 2010-07-26 2013-07-12 Ist Superiore Sanita USE OF TERPINEN-4-OL AS AN ANTIMICROBIAL AGENT AGAINST LEGIONELLA PNEUMOPHILA.
US9492398B2 (en) 2011-02-25 2016-11-15 Eydo Pharma Nanocapsulation of essential oils for preventing or curing infectious diseases alone or with an antibiotic
FR3021218A1 (en) * 2014-05-26 2015-11-27 Eydo Pharma USE OF CINNAMALDEHYDE IN COMBINATION WITH EUGENOL AND / OR CARVACROL TO COMBAT ANTIBIOTIC RESISTANCE
FR3048612B1 (en) 2016-03-14 2020-10-02 Septeos POTENTIALIZED TULATHROMYCIN
GB201904963D0 (en) * 2019-04-08 2019-05-22 Anpario Plc Composition for reducing antimicrobial resistance
WO2021110915A1 (en) * 2019-12-04 2021-06-10 Pranarôm International S.A. Method for transforming an essential oil
CN112618486B (en) * 2020-12-24 2023-07-18 浙江昂利康制药股份有限公司 Suspension oil for injection and preparation method thereof
FR3120187B1 (en) * 2021-02-26 2023-12-01 Mathieu Angelidis Natural repellent composition
CN113633614B (en) * 2021-09-08 2023-04-07 中国人民解放军陆军军医大学 Efficient antibacterial natural tea tree essential oil nanoemulsion preparation for treating intractable dental ulcer and preparation method and application thereof
CN113767937A (en) * 2021-09-10 2021-12-10 江西中医药大学 Compound essential oil composition, preparation method and application

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1146111A1 (en) * 2000-04-14 2001-10-17 The Procter & Gamble Company Process of disinfecting a hard-surface with a composition comprising cinnamon oil and/or an active thereof
US6884763B2 (en) * 2001-10-30 2005-04-26 Permatex, Inc. Waterless hand cleaner containing plant derived natural essential oil
US20040071757A1 (en) * 2001-11-20 2004-04-15 David Rolf Inhalation antiviral patch
EP1562543A1 (en) * 2002-11-21 2005-08-17 J.P.M.E.D. Ltd. Compositions for treating infected skin and mucous membrane comprising an anti-microbial agent and an essential oil
GB0405545D0 (en) * 2004-03-12 2004-04-21 Univ Manchester Antimicrobial composition
WO2006120494A1 (en) * 2005-05-13 2006-11-16 Advanced Scientific Developements Pharmaceutical combination comprising an antibacterial agent and an active substance selected from carveol, thymol, eugenol, borneol and carvacrol

Also Published As

Publication number Publication date
EP2175870A1 (en) 2010-04-21
FR2918571B1 (en) 2013-01-11
FR2918571A1 (en) 2009-01-16
WO2009043987A1 (en) 2009-04-09

Similar Documents

Publication Publication Date Title
WO2009043987A9 (en) Antibiotic compositions containing essential oils, prophylaxis and treatment of nosocomial diseases
WO2008092006A3 (en) Antimicrobial compositions
BRPI1007379B8 (en) pharmaceutical compositions for the treatment or prevention of oral infections by e. coli
AU2003241345A1 (en) Use of mastic and its components for the control of microbial infections
MX2009005603A (en) Antibacterial polycyclic urea compounds.
NZ701559A (en) Compositions comprising povidone-iodine
WO2008020227A3 (en) Antibacterial pyrrolecarboxamides
WO2008020229A3 (en) Antibacterial pyrrolecarboxamides
NO20092542L (en) Antibacterial quinoline derivatives
NZ593831A (en) Compositions and methods for the treatment or prevention of staphylococcus aureus infections and for the eradication or reduction of staphylococcus aureus on surfaces
DK1506214T3 (en) 6-11 bicyclic ketolide derivatives
EA033311B1 (en) Benzoxaborole derivatives as antibacterial agents
WO2006108681A3 (en) Substances and pharmaceutical compositions for the inhibition of glyoxalases and their use against bacteria
WO2009019708A3 (en) Pharmaceutical compositions and methods for the treatment of cancer
NO20092547L (en) Antibacterial quinoline derivatives
WO2006063039A3 (en) 3, 6-bicyclolides
WO2007044927A3 (en) 6, 11-bridged tricyclic macrolides
WO2006039263A3 (en) NOVEL BICYCLIC 9a-AZALIDE DERIVATIVES
NO20092536L (en) Antibacterial quinoline derivatives
NO20092540L (en) Antibacterial quinoline derivatives
WO2006094143A3 (en) Non-systemic antibiotic formulations and related method of use and treatment of upper respiratory infections
WO2005067564A3 (en) 6-11 bicyclic erythromycin derivatives
NO20092541L (en) Antibacterial quinoline derivatives
WO2006065721A3 (en) 11, 12-lactone bicyclolides
SI2079441T1 (en) Topical antibiotic composition for the prevention of lyme disease

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08834729

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

REEP Request for entry into the european phase

Ref document number: 2008834729

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2008834729

Country of ref document: EP